logo
ProjectActive

Weigao Asia

Sector: Hospital • Location: East Asia and Pacific Region

Source: International Finance Corporation (IFC)

Shandong Weigao Group Medical Polymer Company Limited, (“Weigao” or the “Company” - ) listed on the Hong Kong Stock Exchange, is a leading domestic manufacturer of single-use medical devices in China.Weigao is organized into six operating divisions: (i) medical device products (infusion set, syringes, medical needles, pre-filli

Status
Prospective
Sector
Hospital, Warehouse, Manufacturing (Industrial), Residential, Government
Location
Unknown (East Asia & Pacific)
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Weigao Asia

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Weigao Asia” is an infrastructure initiative in the Hospital sector, located in East Asia and Pacific Region. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Shandong Weigao Group Medical Polymer Company Limited, (“Weigao” or the “Company” - http://en.weigaogroup.com/index.php/home/category/index/sc_id/index.php) listed on the Hong Kong Stock Exchange, is a leading domestic manufacturer of single-use medical devices in China.Weigao is organized into six operating divisions: (i) medical device products (infusion set, syringes, medical needles, pre-filling syringes), (ii) orthopedic products, (iii) interventional products; (iv) pharma packaging products; (v) blood management products; and (vi) others. Weigao’s manufacturing operations are situated mainly in Weihai, Shandong Province. Weigao also has a number of other subsidiaries in the group, viz.: Weigao Medical Device; Weigao Orthopedic and Argon Medical (in United States).The proposed financing package will consist of: (i) an A loan of up to US$250 million; and (ii) debt mobilization of up to US$100 million equivalent from other development finance institution (“DFI”) in the form of a straight senior loan, as well as potential core mobilization from other financial institutions. The proposed financing is to support Weigao: (i) to upgrade its manufacturing facilities in China, including up to US$150 million of green capital expenditure for improving resource efficiency in production; (ii) to support its Southeast Asia expansion; and (iii) for research and development (R&D) of new products to further diversify its product portfolio (the “Project”).IFC supported previous projects with the Company as follows: “Weigao GreenBond” in 2019 (https://disclosures.ifc.org/project-detail/ESRS/43238/weigao-greenbond) “Weigao II” in 2014 (https://disclosures.ifc.org/project-detail/ESRS/34313/weigao-ii ); and “Weigao” in 2006 (https://disclosures.ifc.org/project-detail/ESRS/25099/weigao). Ongoing supervision of the existing investments indicates the Company’s environmental and social performance is generally satisfactory.

Original sector

other

Location

Country

Unknown (East Asia & Pacific)

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Hospital, Warehouse, Manufacturing (Industrial), Residential, Government

Article published date

2026-01-18

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project